← Leaderboards
Daniel Yuhang Li
Stanford University
$292,119
Attributed
$292,119
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $165.9K · FY2022–25$200K$150K$100K$50K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$292,119 · 2
By mechanism
K08$165,888 · 1
F32$126,231 · 1
Top collaborators
No co-investigators on record.
Most similar at Stanford University
Same institution · by research overlap
- Thomas None Quertermous$63,279,401
- Calvin J Kuo$48,363,495
- Mary Red-Horse$7,200,366
- Michael T Longaker$26,931,387
- Thomas H. Leung$2,989,723
Others in their field
Other Rising Stars on “In Vivo”
- Michael Difilippantonio · Leidos Biomedical Research, Inc.$22,364,766
- Sabrina Paganoni · Massachusetts General Hospital$17,050,216
- Suma Babu · Massachusetts General Hospital$17,050,216
- Kevin V Grimes · Stanford University$14,783,804
- Xuping Xie · University Of Texas Med Br Galveston$13,737,799
- Heinz Ernst Moser · University Of Texas Med Br Galveston$12,973,432
Research focus
In VivoMediatingGeneticGenomic LocusKnock-OutMapsDisorder RiskGenesGenetic TranscriptionGenome Wide Association StudyEpigenetic ProcessAnatomyLipidsBindingCellsCell LineageArterial Fatty StreakChromatinCoronaryBlood VesselsAtac-SeqCoronary ArteriosclerosisAtherosclerosisMigration
Grant awards (3)
ZEB1 Mediated Coronary Artery Disease Risk in Vascular Smooth Muscle$165,888
K08 · FY2025 · HL · contact PI
TCF21 is a causal coronary artery disease gene that modulates coronary smooth muscle phenotypic transition via epigenetic mechanisms$59,441
F32 · FY2023 · HL · contact PI
TCF21 is a causal coronary artery disease gene that modulates coronary smooth muscle phenotypic transition via epigenetic mechanisms$66,790
F32 · FY2022 · HL · contact PI